NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Biota Holdings Limited


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
New activities and developments reported by Biota Holdings
2007 AUG 8 ... identify the most recent news developments at Biota Holdings. Report 1: Biota Holdings Limited (ASX:BTA) and CSIRO today announced they have executed an agreement under which Biota ...
Subject: Biota Holdings
Price: $3.00
*
RSV Drug Starts Phase Ia Clinical Trials
2007 JUL 30 ... Biota Holdings Limited and MedImmune Inc. announced the start of a Phase Ia clinical trial for their ...
Subject: Clinical Trial Research
Price: $3.00
*
Officials from Biota Holdings report on recent activities
2007 JUL 10 ... identify the most recent news developments at Biota Holdings. Report 1: Biota Holdings Limited (ASX:BTA) and CSIRO today announced they have executed an agreement under which Biota ...
Subject: Biota Holdings
Price: $3.00
*
Officials from Biota Holdings report on recent developments
2007 JUN 26 ... identify the most recent news developments at Biota Holdings. Report 1: Biota Holdings Limited (ASX:BTA) today announced that its long acting neuraminidase inhibitor (LANI), CS8958, ...
Subject: Biota Holdings
Price: $3.00
*
New activities and developments reported by Biota Holdings
2007 JUN 5 ... identify the most recent news developments at Biota Holdings. Report 1: Biota Holdings Limited (ASX:BTA) today announced that its long acting neuraminidase inhibitor (LANI), CS8958, ...
Subject: Biota Holdings
Price: $3.00
*
Biota to Acquire CSIRO Relenza Royalty
2007 MAY 21 ... Biota Holdings Limited (ASX:BTA) and CSIRO today announced they have executed an agreement under which Biota ...
Subject: Biota Holdings
Price: $3.00
*
Reports from Biota Holdings detail the recent activities
2007 MAY 8 ... facilitate more global collaborations for local biotechnology companies. Biota Holdings Limited (ASX:BTA), a world-leading anti-viral drug development company, is set to improve its ...
Subject: Biota Holdings
Price: $3.00
*
LANI completes Phase I in Japan and to commence Phase I in UK
2007 MAY 7 ... Biota Holdings Limited (ASX:BTA) today announced that its long acting neuraminidase inhibitor (LANI), CS8958, ...
Subject: Bird Flu
Price: $3.00
*
Reports from Biota Holdings describe recent developments
2007 MAY 1 ... of Relenza during the three months ended 31 December 2006. Report 2: Biota Holdings Limited (BTA) welcomed the announcement that GlaxoSmithKline (GSK) has granted its first ...
Subject: Biota Holdings
Price: $3.00
*
News from Biota Holdings highlights the latest developments
2007 APR 16 ... facilitate more global collaborations for local biotechnology companies. Biota Holdings Limited (ASX:BTA), a world-leading anti-viral drug development company, is set to improve its ...
Subject: Biota Holdings
Price: $3.00
*
New reports from Biota Holdings detailed
2007 APR 9 ... of Relenza during the three months ended 31 December 2006. Report 2: Biota Holdings Limited (BTA) announced the appointment of Grant Latta as a non executive director. ...
Subject: Biota Holdings
Price: $3.00
*
Biota Says New Evidence Details GSK's Comprehensive Failures to Support Anti-Influenza Drug Relenza, Compromising Global Preparedness for Avian Flu
2007 APR 9 ... After a two year review of more than 200,000 GlaxoSmithKline (GSK) documents, Biota Holdings Limited today filed an Amended Statement of Claim with the Victorian Supreme Court that Biota ...
Subject: Bird Flu
Price: $3.00
*
Drug Discovery Head Wins Inaugural BioBusiness Award
2007 MAR 19 ... facilitate more global collaborations for local biotechnology companies. Biota Holdings Limited (ASX:BTA), a world-leading anti-viral drug development company, is set to improve its ...
Subject: Drug Development
Price: $3.00
*
Reports summarize new developments from Cytopia
2007 FEB 6 ... other senior executive roles for various public and private companies including Biota Holdings, Willis Ltd, and Sharinga Networks. He has worked in both the U.S. and the U.K. ... identify the most recent news developments at Cytopia. Report 1: Cytopia Limited announced it has broadened its anticancer drug pipeline with the selection of CYT645 as ...
Subject: Cytopia
Price: $3.00
*
News from Cytopia highlights the latest developments
2007 JAN 30 ... other senior executive roles for various public and private companies including Biota Holdings, Willis Ltd, and Sharinga Networks. He has worked in both the U.S. and the U.K. ... identify the most recent news developments at Cytopia. Report 1: Cytopia Limited announced it has broadened its anticancer drug pipeline with the selection of CYT645 as ...
Subject: Cytopia
Price: $3.00
*
Officials at Cytopia announce latest news and research developments
2006 DEC 19 ... other senior executive roles for various public and private companies including Biota Holdings, Willis Ltd, and Sharinga Networks. He has worked in both the U.S. and the U.K. ... identify the most recent news developments at Cytopia. Report 1: Cytopia Limited (CYT) announced that it has filed a supplement to its Investigational New Drug ...
Subject: Cytopia
Price: $3.00
*
New activities and developments reported by Biota Holdings
2006 NOV 13 ... identify the most recent news developments at Biota Holdings. Report 1: Biota Holdings Limited (BTA) welcomed the announcement that GlaxoSmithKline (GSK) has granted its first ...
Subject: Biota Holdings
Price: $3.00
*
Biota reports license grant to manufacture, supply zanamivir in China and other countries
2006 OCT 30 ... Biota Holdings Limited (BTA) welcomed the announcement that GlaxoSmithKline (GSK) has granted its first ...
Subject: Business Update
Price: $3.00
*
Cytopia appoints new chief executive officer
2006 JUL 10 ... other senior executive roles for various public and private companies including Biota Holdings, Willis Ltd, and Sharinga Networks. He has worked in both the U.S. and the U.K. ... Cytopia Limited (CYT) announced that Dr. Kevin Healey, managing director and CEO, has stepped down from ...
Subject: Personnel
Price: $3.00
*
Biota appoints VP of business development
2006 MAY 8 ... Biota Holdings Limited (BTA) announced the appointment of Leigh Farrell, to the role of VP business ...
Subject: Biota Holdings Limited
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login